Therapies

Dendritic Cell Immunotherapy

Dendritic cells are a part of your innate immune system.  They have the unique function of identifying, capturing, and processing antigens, which can help the immune system target cancer cells.  They are effective messengers, as their function is to raise the alarm of the presence of a foreign or mutated cell (such as cancer) and then activate the immune system to destroy those cells.   When cancer is actively growing, this function in the immune system has failed.

Dendritic cell immunotherapy treatment helps the dendritic cells mature in the laboratory so that the immune system functions appropriately again and can resume fighting the cancer naturally. The therapy is produced in our on-site immunotherapy lab, where dendritic cells are separated from a blood sample, matured, and grown in the ideal environment.  The dendritic cells reach maturity after eight days and are rigorously tested before they are administered.

This treatment has demonstrated positive effects in cancer treatment, such as inhibiting tumor growth and metastasis. It can also improve the immune response.

Myeloid precursors, which give rise to dendritic cells and subpopulations of tissue macrophages, are distributed in all body tissues and can repopulate and renew various subpopulations.

Ongoing research may uncover additional uses for Dendritic Cell Therapy:

• Promising research has been made in treating autoimmune diseases such as Crohn’s, Rheumatoid Arthritis, and Psoriasis.
• They can cause direct destruction of viruses.

Dendritic Cell therapy is just one of many immunotherapy treatments offered at Sanoviv in our Cancer Treatment Program.